About the job
Join Axsome Therapeutics, a pioneering biopharmaceutical company at the forefront of transforming the treatment landscape for central nervous system (CNS) disorders. We are dedicated to delivering innovative solutions by pinpointing critical care gaps and developing unique therapeutic products that employ groundbreaking mechanisms of action, ultimately enhancing patient outcomes. Our esteemed neuroscience portfolio features FDA-approved therapies for major depressive disorder, excessive daytime sleepiness linked to narcolepsy and obstructive sleep apnea, as well as migraine treatments. With multiple late-stage development programs targeting a wide array of serious neurological and psychiatric disorders affecting over 150 million individuals across the United States, we are united in our mission to address some of the most challenging brain-related issues, allowing patients and their families to thrive. To learn more, visit us at www.axsome.com and connect with us on LinkedIn.

